Form 4: 10x Genomics CEO Sells Shares
Insider Transaction (Form 4)
Serge Saxonov, Chief Executive Officer and a Director of 10x Genomics, Inc., sold 18,545 shares of common stock on August 24, 2026 for $63.02 per share.
Summary
- Open-market sale: disposed of 18,545 Class A Common Stock at $63.02 ($1,168,775) on August 24, 2026; holds 1,085,835 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,168,775 of stock on the open market.
Insider Transactions
Serge Saxonov — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Class A Common Stock | 18,545 | $63 | $1.2M | 1,085,835 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (18,545 shares) |
Keywords
insider transaction, Form 4, TXG, 10x Genomics, Inc., bearish, Serge Saxonov
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.